DFCO yields 7142.86% · PFE yields 6.20%● Live data
📍 DFCO pulled ahead of the other in Year 1
Combined, DFCO + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DFCO + PFE for your $10,000?
Dalrada Financial Corporation and its subsidiaries provide clean energy, healthcare, technology, and precision engineering solutions. It operates through Engineering, Health, Information Technology, Education, and Corporate. The company engages in the manufacture and distribution of medical disposables, hospital equipment and furniture, medical devices, and laboratory and dental products, as well as sanitizing, disinfectant, and PPE products and services; and provision of mechanical contract services. It also provides advanced solutions for the harvesting and recycling of energy to maximize the capture and reuse of thermal energy for integrated heating and cooling applications, such as industrial, commercial, and residential sectors. In addition, the company offers software and technology solutions that specializes in test engineering, accessibility engineering, product engineering and application modernization; cleaning solutions using electrostatic machines to spray and deodorize residential spaces, healthcare facilities, hospitality, transportation, manufacturing, automotive, schools/education systems, and other facilities. Further, it provides trained nursing and medical assistants for hospitals and home health facilities; and regenerative therapy as a potential solution for the prevention, detection, and treatment of cellular breakdown associated with aging and various other conditions, as well as explores various products and services within the immunization and personal protective equipment industry. The company has operations in Malaysia, India, the United Kingdom, and the United States. Dalrada Financial Corporation was founded in 1982 and is based in Escondido, California.
Full DFCO Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.